Citation Impact
Citing Papers
Impact of Androgen-Deprivation Therapy on Cognitive Function in Men With Nonmetastatic Prostate Cancer
2010
The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
2020 Standout
Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging
2002
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma
2000
From Diagnosis to Death: A Case Study of Coping With Breast Cancer as Seen Through Online Discussion Group Messages
2011
Management of cancer pain
1999 Standout
Use of bisphosphonates for the treatment of bone metastasis in experimental animal models
1999
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Breast cancer
2016 Standout
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Inventory of prostate cancer predictive tools
2008
A Systematic Overview of Radiation Therapy Effects in Skeletal Metastases
2003
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial
2008
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
2000
Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide
2008
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
2007
Effectively nursing patients receiving aromatase inhibitor therapy
2008
Predictors of skeletal complications in patients with metastatic breast carcinoma
2000
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
2020
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Screening for bladder cancer: a perspective
2007
Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy
2012
Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment
2008
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial
2017
Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer
2013
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
2006 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
The Effects of Expressive Writing Interventions for Patients With Cancer: A Meta-Analysis
2016
A CATALOG OF PROSTATE CANCER NOMOGRAMS
2001
Does the Internet Change How We Die and Mourn? Overview and Analysis
2012 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
2002
Effectiveness of nursing interventions among patients with cancer: An overview of systematic reviews
2018 Standout
Critical Review of Prostate Cancer Predictive Tools
2009
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial
2003
Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group
2003
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Adherence to Oral Endocrine Therapy for Breast Cancer: A Nursing Perspective
2008
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of David Bloomfield being referenced
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer
2006
Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study
2005
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer
2015
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.
1998
Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.
1998
Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer
2009
The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study
2004
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses
2011
The changing pattern of management for hormone-refractory, metastatic prostate cancer
2006
Identification of intermediate-risk prostate cancer patients treated with radical radiotherapy suitable for neoadjuvant hormone studies
1996
FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015)
2018
Impact of Prostate Cancer Hypofractionation on Patient Reported Outcomes: Baseline to 5 Years Change in the CHHIP Trial
2018
Does Neoadjuvant Hormone Therapy for Early Prostate Cancer Affect Cognition? Results From a Pilot Study
2006